论文部分内容阅读
随着人口老龄化、饮食结构和环境因素的改变以及医疗保健水平的提高,我国前列腺癌发病率呈逐年上升趋势,已跃居男性泌尿和生殖系统恶性肿瘤的第3位。在欧美国家,前列腺癌是男性中最常见的恶性肿瘤,据统计2007年,美国有218 800例前列腺癌新发病例及27 050位患者死于该疾病。如何提高前列腺癌的早期检出及有效的疗效评估对制定治疗方案及改善患者预后有很大的意义。
With the population aging, changes in dietary and environmental factors and the improvement of medical care, the incidence of prostate cancer in our country has been increasing year by year, and ranks third in male urological and reproductive system malignancies. In Europe and the United States, prostate cancer is the most common malignant tumor in men, according to statistics in 2007, there were 218 800 new cases of prostate cancer in the United States and 27 050 patients died of the disease. How to improve the early detection of prostate cancer and effective evaluation of the efficacy of the development of treatment programs and improve patient prognosis is of great significance.